Your browser doesn't support javascript.
loading
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children.
Siemens, Angela; Brooks, Beth; Rassekh, S Rod; Meijer, Annelot J M; van den Heuvel-Eibrink, Mary M; Xu, Wei; Loucks, Catrina M; Ross, Colin J D; Carleton, Bruce C.
Affiliation
  • Siemens A; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Brooks B; BC Children's Hospital Research Institute, Vancouver, Canada.
  • Rassekh SR; Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Meijer AJM; BC Children's Hospital Research Institute, Vancouver, Canada.
  • van den Heuvel-Eibrink MM; Division of Oncology, Hematology and Bone Marrow Transplant, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  • Xu W; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Loucks CM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Ross CJD; Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Carleton BC; Department of Biostatistics, Dalla Lana School of Public Health, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Ther Drug Monit ; 45(3): 345-353, 2023 06 01.
Article in En | MEDLINE | ID: mdl-36917731
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ototoxicity / Hearing Loss / Antineoplastic Agents Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Ther Drug Monit Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ototoxicity / Hearing Loss / Antineoplastic Agents Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Ther Drug Monit Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States